TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives $11.56 Consensus Price Target from Brokerages
TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten ratings firms that are presently covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average […]
TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten ratings firms that are presently covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average […]
